Clinical guidelines for the treatment of depressive disorders. II. Management principles;Lignes directrices cliniques du traitement des troubles dépressifs. II. Principes de la prise en charge

Canadian Journal of Psychiatry

Volumn 46, Issue SUPPL., 2001, Pages

  Reesal, Robin T ^a   Lam, Raymond W ^a   Kennedy, Sidney H ^a   Enns, Murray W ^a   Kutcher, Stanley P ^a   Parikh, Sagar V ^a   Ravindran, Arun V ^a   Segal, Zindle V ^a   Thorpe, Lilian ^a   Vincent, Pierre ^a   Whitney, Diane K ^a  

^a Centre Traitement de la Depression   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; NORTRIPTYLINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

DEPRESSION; HUMAN; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW;

EID: 0035690266     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. The teaching of case formulation in Canada
2. Formulation: A multiperspective model
3. Major depression in 1998: Are we providing optimal therapy?
4. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence
5. Long-term treatment of depression
6. Guidelines for the psychotherapies in comprehensive psychiatric care: A discussion paper
7. The generalizability of the psychoanalytic concept of the working alliance
8. Factors in outcome of short term dynamic psychotherapy for chronic versus non-chronic major depression
9. Relations between working alliance and outcome in psychotherapy: A meta-analysis
10. Therapeutic alliance and outcome in a VA intensive case management program
11. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health treatment of depression collaborative research program
12. The role of the alliance in the pharmacologic treatment of depression
13. Medication compliance in mood disorders: Relevance of the health belief model and other determinants
14. Shared mental health care
15. Guidelines for prescribing psychiatrists in consultative, collaborative, and supervisory relationships
16. E-psychiatry: The patient-psychiatrist relationship in the electronic age
17. Clinical issues in long-term treatment with antidepressants
18. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders
19. Development of a rating scale for primary depressive illness
20. A new depression scale designed to be sensitive to change
21. Comparison of Beck depression inventories -IA and -II in psychiatric outpatients
22. Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning
23. The practice and roles of the psychotherapies: A discussion paper
24. A controlled study of effectiveness and patient suitability for short-term group psychotherapy
25. The psychological mindedness scale: Factor structure and relationship to outcome of psychotherapy
26. Object relations theory and short-term dynamic psychotherapy: Findings from the quality of object relations scale
27. Impact of perfectionism and need for approval on the brief treatment of depression: The National Institute of Mental Health treatment of depression collaborative research program revisited
28. Clinical management-imipramine/placebo administration manual. NIMH treatment of depression collaborative research program
29. The art of clinical management in pharmacologic trials with depressed elderly patients: Lessons from the Pittsburgh study of maintenance therapies in late-life depression
30. The role of the primary care physician in patients' adherence to antidepressant therapy
31. Pharmacologic treatment of acute major depression and dysthymia
32. Optimal length of continuation therapy in depression A prospective assessment during long-term fluoxetine treatment
33. Long term pharmacological treatment of mood disorders
34. Long-term nature of depression
35. Discontinuing antidepressant treatment in major depression
36. The SSRI discontinuation syndrome
37. Suicide risk in patients with major depressive disorder
38. The assessment, management, and treatment of suicidality: Toward clinically informed and balanced standards of care
39. Inpatient standards of care and the suicidal patient
40. Protective factors against suicidal acts in major depression: Reasons for living
41. Treating impulsivity and anxiety in the suicidal patient
42. Effects of medical interventions on suicidal behavior. Summary and conclusions
43. Managing suicidal inpatients
44. The Clarke Institute experience with completed suicide: 1966 to 1997
45. Psychiatric stress debriefing. Alleviating the impact of patient suicide and assault
46. Staffresponse to inpatient and outpatient suicide: What happened and what do we do?
47. The importance of the first three days: Predictors of treatment outcome in depressed in-patients
48. Epidemiology, assessment, and management of suicide in patients with depression
49. Mental health statistics, 1982-83 to 1993-94
50. Decreasing length of stay: Are there effects on outcomes of psychiatric hospitalization?
51. Code of ethics of the Canadian Medical Association
52. Bioethics for clinicians: 8. Confidentiality
53. Confidentiality in crisis: Part I-The duty to inform
54. Confidentiality in crisis: Part II-Confidentiality of treatment records
55. Risk assessments for acute violence to third parties A review of the literature
56. Assessment of psychiatric patients' risk of violence toward others
57. Defining the physician's duty to warn: Consensus statement of Ontario's medical expert panel on duty to inform
58. Driver suicides
59. Liability in prescribing choice: The example of the antidepressants
60. Psychiatrists' documentation of informed consent
61. Psychiatric aspects of suicidal behavior: Depression